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ABSTRACT 
 
Background: Tamoxifen treatment induced cell death in the hippocampus formation of the prenatal and 
postnatal rat.  The present study delineates the effect of tamoxifen on developing hippocampus in prenatal, 
postnatal and full term neonate rats received certain doses of the partial antagonist tamoxifen. Methods: After 
perfusion and fixation, the brains were removed and processed for light and electron microscopy. The 
morphology, ultrastructure and the density of the neurons in different ages (E22, P1, P7 and P21) and in 
different areas of developing hippocampus including cornu ammonis (CA1 and CA3), dentate gyrus and 
subiculum were studied. Results: These findings showed that in tamoxifen-treated groups, the cell number of 
pyramidal neurons of CA1 and subiculum significantly decreased comparing to control groups in E22, P1 and 
P7 but not in third weeks. The mitochondria of the above mentioned groups also showed a dilated feature with 
less cristae than control group and most of them were greatly enlarged and swollen into spherical shapes 
rather than the normal ovoid or rod shape. Conclusion: The present study shows that prenatal exposure to 
tamoxifen alters neurogenesis in developing rat hippocampus. These results demonstrated the non-
neuroprotective roles of tamoxifen.  Iran. Biomed. J.  13 (4): 171-177, 2009  
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INTRODUCTION 
 
amoxifen is widely recognized as an estrogen 
antagonist because it has ability to block or 
attenuate estrogen-induced response in 
several target tissues. Anti-estrogenic effects of 
tamoxifen including suppression or growth in 
estrogen receptor-positive breast cancers [1], 
blocking uterine growth in rats and hamsters, and 
oviduct growth in chicks and quail [2] are well-
documented. These findings presented that 
tamoxifen functions as an antagonist or agonist may 
be both tissue and species specific. 
Estrogen also has a deep effect on structure and 
function of hippocampus that is accepted to play an 
important role in learning and memory. 
Interestingly, most observed effects of estrogen have 
been restricted to CA1 pyramidal neurons and 
interneurons of dorsal hippocampus, a region that 
contains only a few, scattered estrogen receptor-
positive neurons [3-7]. To our knowledge, the non-
neuroprotective role [1] of tamoxifen is mostly 
restricted to the certain areas of the brain and 
concerning different means; CA1, CA2, CA3 and 
dentate gyrus (DG)} areas of hippocampus. We also 
studied developmental effects of tamoxifen on CA1, 
CA3, DG and subiculum of the hippocampus of the 
neonate and postnatal rat. Evaluation of 
ultrastructural neurons in mentioned hippocampal 
areas including cell density and cell size was 
examined in the present study. 
 
 
MATERIALS AND METHODS 
 
All animal procedures were approved by the 
Institutional Animal Care and Use Committee (Iran 
University of Medical Sciences, Tehran). In the 
present study, 60 male and female Wistar rats (180-
200 g, Hesarak Institute, Karaj) were used. The 
animals were individually housed in regular 
polyethylene cages (35 cm long, 22 cm wide and 18 
cm deep) with ad libitum access to food and water in 
a 12:12 h light/dark vivarium and appropriate 
T 
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temperature. A vaginal smear from each female rat 
was examined daily and rats entering estrus were 
mated with adult males. Vaginal smears of mated 
females were examined on the following morning. If 
sperm was observed, this day was designated as Day 
1 of pregnancy and the pregnant females were 
housed in separate cages.  One day prior to labor 
(E21) and on the childbirth day (E22) pregnant rats 
received tamoxifen (250 µg i.p.) twice daily. 
Animals at the same gestational age were used as 
control. Control animals were mated similar to test 
rats and received equal amount of the solvent 
(propylene glycol). Six hours after the last injection, 
the brains were removed and hippocampi were 
isolated as described [1].  
 The animals were divided in three groups: sham, 
control and experiment. Each group was further 
divided into 4 following subgroups: 6 hours after the 
last injection of tamoxifen (E22), 16 hours after birth 
(P1), one week after birth (P7), and three weeks after 
birth (P21). Each subgroup contained 6 rats [8] and 
animals at the same gestational age were used as 
controls. The animals were deeply anesthetized with 
sodium pentobarbital (for mother and neonate 20 
and 5 mg/kg intraperituneum, respectively). Then, 
they were perfused and fixed transcardially by 
Ringer’s solution containing heparin (1 IU/ml), 
immediately followed by Karnovsky’s solution (20-
30 ml/min for 10 min). The brains of prenatal and 
postnatal animals were removed and processed for 
light and electron microscopic study.  
In the light microscopic study, the brains were 
postfixed in Karnovsky's solution overnight, then 
dehydrated with increasing concentration of ethanol 
and finally infiltrated and embedded with paraplast. 
By using freezing microtome, 10 µm coronal 
sections were prepared. Nissl and toluidine blue 
staining were done for all the specimens selected for 
light microscopic study. The sections were observed 
by using an Olympus photomicroscope (PROVIS 
AX70, Japan) and an Olympus digital camera 
(DP11, Japan).  
Electron microscopy was conducted for only CA1 
region. After perfusion and fixation, the brains were 
removed and postfixed in Karnovsky's solution 
overnight and 2% osmium tetroxide in 0.2 M in 
sodium phosphate buffer was used as secondary 
fixative. Certain blocks (1-1.5 mm thick) of CA1 
region of hippocampus were prepared, then 
dehydrated with increasing concentration of acetone, 
further washed with acetone, saturated with Epon 
812, embedded in capsules, and left to polymerize. 
Semithin (0.1-0.3 µm) or ultrathin (60-80 nm) 
sections were cut using an ultramicrotome. Semithin 
sections were mounted on glass slides, stained  
with toluidine blue and examined with light 
microscopy. After trimming, ultrathin sections were 
then mounted on copper grids, stained with uranyl 
acetate and lead citrate and examined with Leo  
906, Zeiss, Germany electron microscopy at 
different magnification. 
The values from each hippocampal area were 
considered as an individual group. Numerical 
densities reported are averages for all blocks in an 
age group with standard error of the mean. Data 
were analyzed using SYSTAT V 11.0 (SPSS) and 
analysis of independent samples t-test was 
performed on all groups.  
 
 
RESULTS 
 
Our study showed the following results for light 
and electron microscopy, respectively. Light 
microscopic examination showed a significant 
decrease in cell number on pyramidal neurons of the 
CA1, exposed to tamoxifen in E22, P1 and P7 but 
not in third week. Thus, there was a significant 
interaction between development and tamoxifen 
treatment. Tamoxifen significantly altered the 
number of cells on the pyramidal cell of 
hippocampus CA1 subregion, but not in third week. 
Also, neuronal density in subiculum was decreased a 
little such that tamoxifen treatment prevented to 
increase the cell number (Fig. 1).  
Our findings show that the number of pyramidal 
neurons of CA1 and subiculum was significantly 
decreased in tamoxifen-treated rats in E22, P1, and 
P7. We found that cellular density is low in early 
stages of development; however, cellular density and 
cellular thickness gradually increased during the 
development particularly in the third week. Our 
findings also showed that tamoxifen had no effects 
on CA3 and DG of all trial groups. Light 
microscopic quantitative examination for both cresyl 
violet and toluidine blue staining revealed 
mitochondrial changes in E22, P1 and P7 but not for 
third week animals. Mitochondria nuclear envelope 
and chromatin distribution of CA1 area of the 
hippocampus were structurally normal in the control 
and sham groups (Fig. 2). Our findings also showed 
that in E22, there were numerous shrinkage nuclei 
and clumping or aggregation of chromatin 
distribution, and also disruption of nuclear envelope 
(Fig. 3). 
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Fig. 1. Quantitative analysis of the effects of developmental 
stages and tamoxifen treatment on cell number. The number of 
cells was counted in relation to the subregion and age. (A) 
Tamoxifen significantly reduced the cell number in CA1 
subregion to first week and demonstrated no effects in third 
week. (B) Tamoxifen did not alter the cell number in CA3 
subregion in all ages. (C) Tamoxifen did not alter the cell 
number in D.G. subregion at either age. (D) Tamoxifen reduced 
the number of cells in subiculum to first week and demonstrated 
no effects on in third weeks. Data are expressed as mean ± 
SEM. *P<0.05; **P<0.01 significantly different from Control.  
In view of electron microscopy, only CA1 region 
of hippocampus of E22, P1 and P21 was studied. No 
signs of degeneration were seen in control animals 
and mitochondria appeared as electron-dense 
structure with regular cristae inside and displayed 
smooth membrane and condensations of nuclear 
chromatin.  Neither  cytoplasm  membrane  nor their 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Photomicrograph of Nissl staining of CA1 neurons of 
E22 (A1, A2), P1 (B1, B2), P7 (C1, C2), and P21 (D1, D2) of 
control (Control) and tamoxifen-treated (Experiment) animals. 
In the control groups the thickness of the layers increases from 
E22 to P21 and neurons are being matured. In the experimental 
groups damaged neurons (arrowheads) are heavily stained and 
dense nuclei with irregular nuclear membrane (short thin 
arrows), nuclear shrinkage (thick arrows), and chromatin 
clumping (long thin arrows) are marked. P21 is the least affected 
area and exhibited shrunken and triangulated neuronal body 
with a possible lightly reaction in the immediate vicinity. 
Majority of neurons in P21 area are morphologically unaltered 
and similar in form and staining to those in the control tissue. 
Photomicrographs are representative of n = 8. Scale bars = 250 
µm. 
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 Fig. 3. Photomicrograph of semi-thin sections blue staining of 
CA1 neurons of E22 (A), P1 (B), P7 (C) and P21 (D). (E22) 
shows more changes than P1 and P7. Some neurons exhibit 
additional heterochromatin staining. Also photograph revealed 
irregular nuclear membrane (thin arrow), chromatin clumping 
(white arrowheads) cytoplasm vacuolated (thick arrows), and 
dense nuclei (black arrowheads). P21 seemed to be the least 
affected area, this data confirm the Nissl staining studies. Scale 
bars = 100 µm 
 
organelles showed any signs of morphological 
abnormalities. In P21 groups in compared to the 
sham groups animals, we observed low changes in 
ultrastructure (Fig. 4). In CA1 area of E22, P1 and 
P7, degenerated neurons were seen. Damaged cells 
were electron-dense with irregular shape and 
disruption of nuclear membrane, pyknosis and 
shrinkage of nucleus, condensation and clumping of 
chromatin in nucleus. The mitochondria of the 
mentioned above groups also showed dilated feature 
with low cristae than control group, most of them 
were greatly enlarged and swollen into spherical 
shapes rather than the normal ovoid or rod shape 
(Fig. 4). Less frequently, enlarged and structurally 
abnormal mitochondria were also founded in the 
CA1 region of P1. Mild degrees of spherical 
mitochondrial swelling occurred in P7 and to lesser 
extent in P21. Fewer changes were seen in the CA3 
and DG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Electron micrographs of CA1 hippocampal neurons of 
control (A, B), E22 (C, D), P1 (E), P7 (F, G) and P21 (H). 
Fragmentation with irregular nuclear membrane , disrupted 
nuclear membrane, nuclear shrinkages and chromatin clumping 
of CA1 neuron of E22, P1, P7 and P21. Neuron of CA1 region 
of control animals (A) have oval mitochondria (M) with regular 
cristae (short thick arrow), nucleus (N) with occasional 
condensations of nuclear chromatin (long thin arrows), but in 
damaged cells after tamoxifen treatment mitochondria appeared 
dilated (long thick arrow) and fewer cristae. Nucleus of some 
neurons showed clumping and marginalization (O) chromatin. 
Nuclear membrane shows enfolding and disruption 
(arrowheads). Scale bars = 50 µm. 
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DISCUSSION 
 
Our findings indicate that tamoxifen treatment of 
pregnant rats could affect hippocampus formation in 
prenatal and postnatal rat. Based on our results, we 
believe that tamoxifen might be the main cause of 
these alterations in different areas of the 
hippocampus. Our results in some parts agreed with 
the results reported by other researchers [9, 10, 1].  
The most conspicuous finding was in the nucleus 
and mitochondria. The nucleus in some neurons was 
extremely shrunken and darkened whereas in others 
the nucleus was clumping or contained marginated 
chromatin [9]. According to the literature, these 
cellular characteristic could be considered as 
apoptotic changes in CA1 region in tamoxifen 
treatment. Therefore, in early neonatal rat 
hippocampus, tamoxifen prevents to increase the 
number of cell. These results demonstrated the non-
neuroprotective roles of tamoxifen. In addition  
to apoptotic cells, some other neurons showed 
different morphological patterns of cell death that 
probably reflects different stages of the cell death 
process [11]. 
Studies have indicated that tamoxifen causes 
significant alterations of the nucleus and 
mitochondria of certain central nervous system 
regions. The nuclei of certain neurons were 
extremely shrunken and darkened whereas in other 
neurons, nuclei were clumping and contained 
marginated chromatin [12, 13]. 
It has been shown that the decrease in cell number 
might be tamoxifen-dependent and any changes in 
the hippocampal formation may occur following 
manipulation in the level of estradiol and 
progesterone [14, 15]. 
It has been also reported that estrogen treatment 
could prevent cell death of pyramidal neurons in the 
CA1 region and subiculum [9-16]. Age-related 
changes in the number of the neurons of different 
regions of rat hippocampus that were shown in our 
study had been reported by other researchers [17-
20]. It has been shown that ageing could form the 
number of neurons across all regions of the 
hippocampal formation [17, 21, 22].  There are some 
reports that claim the number of the neurons within 
CA3 region is constant throughout the life [23-25]. 
 In addition to apoptotic cells, other neurons 
showed different morphological patterns of cell 
death that might reflect different stages of the cell 
death process [26, 27]. It has been reported that 
decrease in cell number in the hippocampus might 
be NOS-dependent and changes in hippocampal 
formation occur following alteration of the estradiol 
and progesterone levels [28-30]. 
Tamoxifen treatment also produced mitochondrial 
and nucleus abnormalities as seen by Pliss et al. [31] 
and Song et al. [32]. Moreover, it is the same for the 
mitochondria of CA1 neurons [33]. Studies in 
tamoxifen-treated animal models have also reported 
the enlargement of mitochondria along with 
disruptions of mitochondria cristae [33-35]. These 
changes might occur across with cell death process 
of the neurons [36, 37]. The results of this 
developmental study suggest that CA1 region in 
hippocampus is much sensitive to tamoxifen 
because, our results revealed the morphological and 
ultrastructural changes in this area. 
 
 
ACKNOWLEDGEMENTS 
 
The authors are grateful to Ms. F. Mohammad-
zadeh for her technical assistance. Also, the authors 
would like to appreciate Cellular and Molecular 
Research Center of Iran University of Medical 
Sciences for support and assistance. 
 
 
REFERENCES 
 
1. Silva, I., Mello, L.E.A.M., Freymuller, E., Haidar, 
M.A. and Edmund, B.C. (2000) Estrogen, 
progestogen and tamoxifen increase synaptic density 
of the hippocampus of ovariectomized rats. Neurosci. 
Lett.  291 (3): 183-186. 
2. Luine, V.N., and McEwen, B.S. (1977) Effects of 
stradiol on turnover of type-A monoamine-oxidase in 
brain. J. Neurochem., 28: 1221-1227. 
3. Shughrue, P.J. and Merchenthaler, I. (2003) Estrogen 
prevents the loss of CA1 hippocampal neurons in 
gerbils after ischemic injury.  Neuroscience  116 (3): 
851-861. 
4. Shughrue, P.J., and Merchenthaler, I. (2001) 
Distribution of estrogen receptor β immunoreactivity 
in the rat central nervous system. J. Comp. Neurol. 
436: 64-81. 
5. Shughrue, P.J. and Merchenthaler, I. (2000) Evidence 
for novel estrogen binding sites in the rat 
hippocampus.  Neuroscience  99 (4): 605-612. 
6. Shughrue, P.J., Lane, M.V. and Merchenthaler, I. 
(1997) Comparative distribution of estrogen receptor-
α and β mRNAs in the rat central nervous system.  J. 
Comp. Neurol.  388: 507-525. 
7. Weiland, N.G., Orikasa, C., Hayashi, S. and 
McEwen, B.S. (1997) Distribution and hormone 
regulation of estrogen receptor immunoreactive cells 
in the hippocampus of male and female rats. J. Comp. 
176                                                                                            Nobakht  et al.                                             Iran. Biomed. J., October 2009 
 
http://IBJ.pasteur.ac.ir 
Neurol.  388 (4): 603-612. 
8. Weiner, C.P., Lizasoain, I., Baylis, S.A., Knowles, 
R.G., Charles, I.G. and Moncada, S. (1994) Induction 
of calcium-dependent nitric oxide synthases by sex 
hormones.  Proc. Natl. Acad. Sci. USA   91 (11): 
5212-5216. 
9. Islam, A., Westman, J., Bogdanovic, N., Suliman, 
I.A., Lindell, I., Winblad, B. and Adem, A. (1999) 
Ultrastructural analysis of the hippocampus of adult 
rats after long-term adrenalectomy. Brain Res.  849 
(1-2): 226-230. 
10. MacGregor, J.I. and Jordan, V.C. (1998) Basic guide 
to the mechanisms of anti-estrogen action. 
Pharmacol. Rev.  50 (2): 151-196. 
11. Wilcox, B.J., Applegate, M.D., Portera-Cailliau, C. 
and Koliatsos, V.E. (1995) Nerve growth factor 
prevents apoptotic cell death in injured central 
cholinergic neurons.  J. Comp. Neurol.  395 (4): 573-
585. 
12. Parihar, A., Parihar, M.S. and Ghafourifar, P. (2008) 
Significance of mitochondrial calcium and nitric 
oxide for apoptosis of human breast cancer cells 
induced by tamoxifen and etoposide.  Int. J. Mol. 
Med.  21 (3): 317-324. 
13. Satake, A., Takaoka, M., Nishikawa, M., Yuba, M., 
Shibata, Y., Okumura, K., Kitano, K., Tsutsui, H., 
Fujii, K., Kobuchi, S., Ohkita, M. and Matsumura, Y. 
(2008) Protective effect of 17beta-estradiol on 
ischemic acute renal failure through the 
PI3K/Akt/eNOS pathway.  Kidney Int.  73 (3): 308-
317 
14. Weiland, N.G. and Orchinik, M. (1995) Specific 
subunit mRNAs of the GABAA receptor are 
regulated by progesterone in subfields of the 
hippocampus.  Brain Res. Mol. Brain Res.  32 (2): 
271-278. 
15. Weiland, N.G. (1992) Glutamic acid decarboxylase 
messenger ribonucleic acid is regulated by estradiol 
and progesterone in the hippocampus.  
Endocrinology  131: 2697-2702. 
16. Pinnock, S.B., Balendra, R., Chan, M., Hunt, L.T., 
Turner-Stokes, T. and Herbert, J. (2007) Interactions 
between nitric oxide and corticosterone in the 
regulation of progenitor cell proliferation in the 
dentate gyrus of the adult rat.  
Neuropsychopharmacology  32 (2) : 493-504. 
17. Devaney, K.O. and Johnson, H.A. (1984) Changes in 
cell density within the human hippocampal formation 
as a function of age.  Gerontology  30 (2): 100-108. 
18. Geinisman, Y., Detoledo-Morrell, L., Morrell, F. and 
Heller, RE. (1995) Hippocampal markers of age-
related memory dysfunction; behavioral, 
electrophysiological and morphological perspectives.  
Prog. Neurobiol.  45 (3): 223-252. 
19. Sapolsky, R.M., Kery, L.C. and McEwen, B.S. 
(1985) Prolonged glucocorticoid exposure reduces 
hippocampal neuron number: implication for aging.  
J. Neurosci.  5: 1222-1227. 
20. Poe, B.H., Linville, C., Riddle, D.R., Sonntag, W.E. 
and Brunso-Bechtold, J.K. (2001) Effects of age and 
insulin-like growth factor-1 on neuron and synapse 
number in area CA3 of hippocampus. Neuroscience  
107 (2): 231-238. 
21. Meaney, M.J., Aitken, D.H., Bahatnagar, S. and 
Sapolsky, R.M.  (1991)  Postnatal handling attenuates 
certain neuroendocrine, anatomical, and cognitive 
dysfunctions associated with aging in female rats.  
Neurobiol. Aging  12 (1): 31-38. 
22. Peters, A., Rosene, D.L., Moss, M.B., Kemper, T.L., 
Abraham, C.R., Tigges, J. and Albert, M.S. (1996) 
Neurobiological bases of age-related cognitive 
decline in the rhesus monkey.  J. Neuropathol. Exp. 
Neurol.  55 (8): 861-874. 
23. Curcio, C.A., and Hinds, J.W. (1983) Stability of 
synaptic density and spine volume in dentate gyrus of 
aged rats.  Neurobiol. Aging  4 (1): 77-87. 
24. Kadar, T., Silbermann, M., Brandeis, R. and Levy, A. 
(1990) Age-related structural changes in the rat 
hippocampus: correlation with working memory 
deficiency.  Brain Res.  512 (1): 113-120. 
25. Landfield, P.W., Braun, L.D., Pitler, T.A., Lindsey, 
J.D. and Lynch, G. (1981) Hippocampal aging in 
rats: a morphometric study of multiple variables in 
semi-thin sections.  Neurobiol. Aging 2 (4): 265-275. 
26. Wilcox, B.J., Applegate, M.D., Portera-Caillau, C. 
and Koliatsos, V.E. (1995) Nerve growth factor 
prevents apoptotic cell death in injured central 
cholinergic neurons.  J. Comp. Neurol.  395 (4) : 
573-585. 
27. Shughrue, P.J. and Merchenthaler,  I. (1999) 
Evidence for novel estrogen binding sites in the rat 
hippocampus.  Neuroscience  99 (4): 605-612. 
28. Veenman, C.L., Lehmann, J., Stöhr, T., Totterdell, S., 
Yee, B., Mura, A. and Feldon, J. (1999)  
Comparisons of the densities of NADPHD reactive 
and nNOS immunopositive neurons in the 
hippocampus of three age groups of young non-
handled and handled rats.  Dev. Brain Res.  114 (2): 
229-243. 
29. Zhou, Q.G., Hu, Y., Hua, Y.,  Hu, M., Luo, C.X., 
Han, X.,  Zhu, X.J., Wang, B., Xu, J.S. and Zhu, D.Y. 
(2007) Neuronal nitric oxide synthase contributes to 
chronic stress-induced depression by suppressing 
hippocampal neurogenesis. J. Neurochem. 103 : 
1843–1854. 
30. Nobakht, M. , Fattahi, M., Samadi, M., Tabatabaei, P. 
and Majidzadeh, S. (2007) Expression of neuronal 
nitric oxide synthase during embryonic development 
of the rat optic vesicle.  Pakistan J. Biol. Sci.  10 (7): 
1078-1082. 
31. Pliss, L. Balcar, V.J., Bubenikova, V., Pokorny, J., 
Fitzgibbon, T. and Stastny, F. (2003)  Morphology 
and ultrastructure of rat hippocampal formation after 
I.C.V. administration of n-Acetyl-L-Aspartyl-L-
Glutamate.  Neuroscience  122 (1): 93-101. 
Iran. Biomed. J., October 2009                       Effects of Tamoxifen on Developing Hippocampus of Rat                                              177 
 
http://IBJ.pasteur.ac.ir 
32. Song, D.D., Shults, C.W., Sisk, S.A., Rockenstein, E. 
and Masliah, E. (2004) Enhanced substantia nigra 
mitochondrial pathology in human α-synuclein 
transgenic mice after treatment with MPTP.  Exp. 
Neurol.  186 (2): 158-172. 
33. Wise, P.M., Dubal, D.B., Wilson, M.E., Rau, S.W. 
and Bottner, M. (2001) Mini review: neuroprotection 
effects of estrogen- new insights into mechanisms of 
actions. Endocrinology. 142 (3): 969-973. 
34. Galceran, J., Miyashita-Lin, E.M., Devaney, E., 
Rubenstein, J.L. and Grosschedi, R. (2000) 
Hippocampus development and generation of dentate 
gyrus granule cells is regulated by LEF1. 
Development  127 (3): 469-482. 
35. Wood, G.E., Young, L.T., Reagan, L.P., Chen, B. 
and McEwen, B.S. (2004) Stress-induced structural 
remodeling in hippocampus: Prevention by lithium 
treatment.  Proc. Natl. Acad. Sci. USA  101 (11): 
3973-3978. 
36. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.T., 
Michel, P.P., Marques, J., Mouatt-Prigent, A., 
Ruberg, M., Hirsch, E.C. and Agid, Y. (1997) 
Apoptosis and autophagy in nigra neurons of patients 
with Parkinson’s disease.  Histol. Histopathol. 12 (1): 
25-31. 
37. Clarke, P.G.H. (1990) Developmental cell death: 
morphological diversity and multiple mechanisms. 
Anat. Embryol (Berl).  181 (3): 195-213. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
